These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14634385)

  • 1. Renal cell carcinoma--prognostic factors.
    Marshall FF
    J Urol; 2003 Dec; 170(6 Pt 1):2233. PubMed ID: 14634385
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment.
    Pomara G; Francesca F
    Urology; 2011 May; 77(5):1146; author reply 1146-7. PubMed ID: 21539964
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment.
    Russo P
    Urology; 2010 Feb; 75(2):275-6; author reply 276. PubMed ID: 20152477
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prognosis in 550 cases with renal cell carcinoma].
    Satomi Y; Fukuda M; Hosaka M; Kondo I; Yoshimura S; Fukushima S; Ida T; Hirokawa M; Morita T; Furuhata A
    Nihon Hinyokika Gakkai Zasshi; 1988 May; 79(5):853-63. PubMed ID: 3236599
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial comment on: external validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Blute ML
    Eur Urol; 2010 Jan; 57(1):110-1. PubMed ID: 19062158
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comment on: External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Giannarini G; Autorino R
    Eur Urol; 2010 Jan; 57(1):109-10. PubMed ID: 19062156
    [No Abstract]   [Full Text] [Related]  

  • 7. [Controversies in surgical therapy of renal cell carcinoma].
    Schröder A; Lampel A; Eggersmann C; Thüroff JW
    Urologe A; 1997 Sep; 36(5):W460-6. PubMed ID: 9424788
    [No Abstract]   [Full Text] [Related]  

  • 8. Rationale for total nephrectomy for suspected renal cell carcinoma.
    Marsh CL; Lange PH
    Semin Urol Oncol; 1995 Nov; 13(4):273-80. PubMed ID: 8595551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the surgical management of localized renal masses.
    Bolton DM
    BJU Int; 2013 Jun; 111(8):1182-3. PubMed ID: 23714644
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment.
    Russo P
    Urology; 2009 May; 73(5):1082. PubMed ID: 19394510
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose interleukin-2 in metastatic renal cell carcinoma.
    Fernández-Rodríguez R; de Argumedo GL; Mañé JM; Muñoz A; Ferreiro J; Fuente N; López-Vivanco G
    J Clin Oncol; 2005 Sep; 23(27):6797-8; author reply 6798-9. PubMed ID: 16170190
    [No Abstract]   [Full Text] [Related]  

  • 12. [Kidney parenchyma carcinoma--diagnosis. German Society of Urology].
    Urologe A; 1998 May; 37(3):328-41. PubMed ID: 9646432
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal cell carcinoma: vena caval involvement.
    Boorjian SA; Sengupta S; Blute ML
    BJU Int; 2007 May; 99(5 Pt B):1239-44. PubMed ID: 17441917
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment to effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: implications for multimodal therapy.
    Gudbjartsson T
    Int J Urol; 2013 Jun; 20(6):579. PubMed ID: 23621609
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of radical nephrectomy in metastatic renal cell carcinoma.
    Flanigan RC; Yonover PM
    Semin Urol Oncol; 2001 May; 19(2):98-102. PubMed ID: 11354539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial comment.
    Kattan MW
    Urology; 2010 Jun; 75(6):1371; author reply 1371-2. PubMed ID: 20513496
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Outcomes following partial nephrectomy by tumor size P. L. Crispen, S. A. Boorjian, C. M. Lohse, T. S. Sebo, J. C. Cheville, M. L. Blute and B. C. Leibovich J Urol 2008; 180: 1912-1917.
    Cimen HI; Serefoglu EC; Balbay MD
    J Urol; 2009 Sep; 182(3):1232; author reply 1232. PubMed ID: 19625039
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytoreductive nephrectomy for pT3b-T4 M1 renal cell carcinoma in 39 patients: single center analysis.
    Takagi T; Kondo T; Iizuka J; Kobayashi H; Hashimoto Y; Tanabe K
    Int J Urol; 2012 Sep; 19(9):875-9. PubMed ID: 22568824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of simplified versions of the Fuhrman nuclear grading system in clinical practice requires the agreement of a multidisciplinary panel of experts.
    Ficarra V; Novara G; Martignoni G
    Eur Urol; 2009 Nov; 56(5):782-4; discussion 784-5. PubMed ID: 19660853
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic factors in renal cell cancer.
    Park WH; Eisen T
    BJU Int; 2007 May; 99(5 Pt B):1277-81. PubMed ID: 17441924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.